European Mannequin-Based Simulation Market by Product, by End-User - Analysis and Forecast to 2019

The purpose of this report is to cover the definition, description, and forecast of the Europe Mannequin-Based Simulation Market. It involves an in-depth analysis of the market segmentation, which comprises submarkets, types, and end-users. This report also provides a deep insight of the strategic analysis of key players in this market. In this report, the Europe mannequin-based simulation market is segmented on the basis of its types and end-users. This market by type is segmented into patient simulators, task trainers, ultrasound simulators, surgical simulators, endovascular simulators, dental simulators, and eye simulators. The end-users are military organizations, academic institutes, and hospitals.
Germany is the largest mannequin-based simulation market growing at a CAGR of 19.9% for the forecast period from 2014 to 2019, in Europe. Its largest share is attributed to the rising adoption of simulation technologies, increasing demand for minimally invasive treatment, and increasing focus on patient safety. This will improve the demand for mannequin-based simulation in these markets. However, the limited availability of funds is a major constraint.
The report also provides a detailed competitive landscaping of the companies operating in this market. Segment and country specific company shares, news & deals, Mergers and acquisitions, segment specific pipeline products, product approvals, and product recalls of the major companies have been detailed. The main companies operating in this market are CAE, Inc. (U.S.), Laerdal Medical AS (Norway), Gaumard Scientific Company Inc. (U.S.), Limbs & Things Ltd. (U.K.), etc.

TABLE OF CONTENTS

1 INTRODUCTION 11
1.1 OBJECTIVES OF THE STUDY 11
1.2 SEGMENTATION & COVERAGE 12
1.3 STAKEHOLDERS 12
2 RESEARCH METHODOLOGY 13
2.1 EUROPEAN INTEGRATED ECOSYSTEM OF MANNEQUIN-BASED SIMULATION MARKET 14
2.2 ARRIVING AT THE MANNEQUIN-BASED SIMULATION MARKET SIZE 14
2.2.1 TOP-DOWN APPROACH 15
2.2.2 BOTTOM-UP APPROACH 16
2.2.3 MACROINDICATOR-BASED APPROACH 17
2.3 ASSUMPTIONS 18
3 EXECUTIVE SUMMARY 19
4 MARKET OVERVIEW 20
4.1 INTRODUCTION 20
4.2 EUROPE MANNEQUIN-BASED SIMULATION MARKET: COMPARISON WITH PARENT MARKET 20
4.3 MARKET DRIVERS AND INHIBITORS 21
4.4 KEY MARKET DYNAMICS 22
5 EUROPE MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 24
5.1 INTRODUCTION 25
5.2 EUROPE: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE (COMPARISON WITH PARENT MARKET) 26
5.3 EUROPE: PATIENT SIMULATORS MARKET, BY GEOGRAPHY 27
5.4 EUROPE: TASK TRAINERS MARKET, BY GEOGRAPHY 27
5.5 EUROPE: SURGICAL SIMULATORS MARKET, BY GEOGRAPHY 29
5.6 EUROPE: ENDOVASCULAR SIMULATORS MARKET, BY GEOGRAPHY 30
5.7 EUROPE: ULTRASOUND SIMULATORS MARKET, BY GEOGRAPHY 31
5.8 EUROPE: DENTAL SIMULATORS MARKET, BY GEOGRAPHY 32
5.9 EUROPE: EYE SIMULATORS MARKET, BY GEOGRAPHY 33
6 EUROPE MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 34
6.1 INTRODUCTION 35
6.2 EUROPE:ACADEMIC INSTITUTES MARKET, BY GEOGRAPHY 36
6.3 EUROPE: HOSPITALS MARKET, BY GEOGRAPHY 37
6.4 EUROPE: MILITARY ORGANIZATIONS MARKET, BY GEOGRAPHY 38
7 EUROPE MANNEQUIN-BASED SIMULATION MARKET, BY GEOGRAPHY 39
7.1 INTRODUCTION 40
7.2 GERMANY: MANNEQUIN-BASED SIMULATION MARKET 41
7.2.1 GERMANY: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 41
7.2.2 GERMANY: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 42
7.3 FRANCE: MANNEQUIN-BASED SIMULATION MARKET 43
7.3.1 FRANCE: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 44
7.3.2 FRANCE: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 45
7.4 U.K.: MANNEQUIN-BASED SIMULATION MARKET 46
7.4.1 U.K.: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 46
7.4.2 U.K.: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 47
7.5 ITALY: MANNEQUIN-BASED SIMULATION MARKET 48
7.5.1 ITALY: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 49
7.5.2 ITALY: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 50
7.6 SPAIN: MANNEQUIN-BASED SIMULATION MARKET 51
7.6.1 SPAIN: MANNEQUIN-BASED SIMULATION MARKET, BY TYPE 51
7.6.2 SPAIN: MANNEQUIN-BASED SIMULATION MARKET, BY END-USER 52
8 EUROPE MANNEQUIN-BASED SIMULATION MARKET: COMPETITIVE LANDSCAPE 54
8.1 EUROPE MANNEQUIN-BASED SIMULATION MARKET: COMPANY SHARE ANALYSIS 54
8.2 COLLABORATION 55
8.3 NEW PRODUCT LAUNCH 56
9 MANNEQUIN-BASED SIMULATION MARKET, BY COMPANY 57
(Overview, Financials, Products & Services, Strategy, and Developments)*
9.1 CAE, INC. 57
9.2 LAERDAL MEDICAL 61
9.3 GAUMARD SCIENTIFIC COMPANY, INC. 68
9.4 KYOTO KAGAKU CO., LTD. 74
9.5 LIMBS & THINGS, LTD. 76
9.6 MENTICE AB 83
9.7 MOOG, INC. 86
9.8 SIMULAB CORPORATION 87
9.9 SIMULAIDS, INC 96
9.10 SURGICAL SCIENCE 102
*Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
?
10 APPENDIX 104
10.1 CUSTOMIZATION OPTIONS 104
10.1.1 LOW-COST SOURCING LOCATIONS 104
10.1.2 REGULATORY FRAMEWORK 104
10.1.3 IMPACT ANALYSIS 104
10.2 RELATED REPORTS 105
10.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 106
10.3.1 RT SNAPSHOTS 107